Literature DB >> 31610721

Opening the time window.

Klaus van Leyen1, Xiaoying Wang1, Magdy Selim2, Eng H Lo1.   

Abstract

Keywords:  Thrombolysis; acute stroke; brain imaging; clinical trials; neuroprotection

Mesh：

Substances：

Year:  2019        PMID： 31610721      PMCID： PMC6893980          DOI： 10.1177/0271678X19882782

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  11 in total

1.  Endocrine Regulator rFGF21 (Recombinant Human Fibroblast Growth Factor 21) Improves Neurological Outcomes Following Focal Ischemic Stroke of Type 2 Diabetes Mellitus Male Mice.

Authors:  Yinghua Jiang; Ning Liu; Qingzhi Wang; Zhanyang Yu; Li Lin; Jing Yuan; Shuzhen Guo; Bum Ju Ahn; Xiao-Jie Wang; Xiaokun Li; Eng H Lo; Xiaochuan Sun; Xiaoying Wang
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

Review 2.  A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion.

Authors:  Ligen Shi; Marcelo Rocha; Rehana K Leak; Jingyan Zhao; Tarun N Bhatia; Hongfeng Mu; Zhishuo Wei; Fang Yu; Susan L Weiner; Feifei Ma; Tudor G Jovin; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-07       Impact factor: 6.200

3.  Comparative transcriptome of neurons after oxygen-glucose deprivation: Potential differences in neuroprotection versus reperfusion.

Authors:  Shuzhen Guo; Anna Tjärnlund-Wolf; Wenjun Deng; Emiri Tejima-Mandeville; Lauren J Lo; Changhong Xing; Ken Arai; MingMing Ning; Yiming Zhou; Eng H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-28       Impact factor: 6.200

Review 4.  The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation.

Authors:  Marilyn J Cipolla; David S Liebeskind; Siu-Lung Chan
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-10       Impact factor: 6.200

5.  Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.

Authors:  Bruce C V Campbell; Henry Ma; Peter A Ringleb; Mark W Parsons; Leonid Churilov; Martin Bendszus; Christopher R Levi; Chung Hsu; Timothy J Kleinig; Marc Fatar; Didier Leys; Carlos Molina; Tissa Wijeratne; Sami Curtze; Helen M Dewey; P Alan Barber; Kenneth S Butcher; Deidre A De Silva; Christopher F Bladin; Nawaf Yassi; Johannes A R Pfaff; Gagan Sharma; Andrew Bivard; Patricia M Desmond; Stefan Schwab; Peter D Schellinger; Bernard Yan; Peter J Mitchell; Joaquín Serena; Danilo Toni; Vincent Thijs; Werner Hacke; Stephen M Davis; Geoffrey A Donnan
Journal:  Lancet       Date:  2019-05-22       Impact factor: 79.321

6.  12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.

Authors:  Yu Liu; Yi Zheng; Hulya Karatas; Xiaoying Wang; Christian Foerch; Eng H Lo; Klaus van Leyen
Journal:  Stroke       Date:  2017-01-05       Impact factor: 7.914

7.  Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.

Authors:  Henry Ma; Bruce C V Campbell; Mark W Parsons; Leonid Churilov; Christopher R Levi; Chung Hsu; Timothy J Kleinig; Tissa Wijeratne; Sami Curtze; Helen M Dewey; Ferdinand Miteff; Chon-Haw Tsai; Jiunn-Tay Lee; Thanh G Phan; Neil Mahant; Mu-Chien Sun; Martin Krause; Jonathan Sturm; Rohan Grimley; Chih-Hung Chen; Chaur-Jong Hu; Andrew A Wong; Deborah Field; Yu Sun; P Alan Barber; Arman Sabet; Jim Jannes; Jiann-Shing Jeng; Benjamin Clissold; Romesh Markus; Ching-Huang Lin; Li-Ming Lien; Christopher F Bladin; Søren Christensen; Nawaf Yassi; Gagan Sharma; Andrew Bivard; Patricia M Desmond; Bernard Yan; Peter J Mitchell; Vincent Thijs; Leeanne Carey; Atte Meretoja; Stephen M Davis; Geoffrey A Donnan
Journal:  N Engl J Med       Date:  2019-05-09       Impact factor: 91.245

8.  Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.

Authors:  Patrick Lyden; Kent E Pryor; Christopher S Coffey; Merit Cudkowicz; Robin Conwit; Ashutosh Jadhav; Robert N Sawyer; Jan Claassen; Opeolu Adeoye; Shlee Song; Peter Hannon; Natalia S Rost; Archana Hinduja; Michel Torbey; Jin-Moo Lee; Curtis Benesch; Michael Rippee; Marilyn Rymer; Michael T Froehler; E Clarke Haley; Mark Johnson; Jon Yankey; Kim Magee; Julie Qidwai; Howard Levy; E Mark Haacke; Miller Fawaz; Thomas P Davis; Arthur W Toga; John H Griffin; Berislav V Zlokovic
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

Review 9.  Extending the Time Window for Endovascular and Pharmacological Reperfusion.

Authors:  Nils Henninger; Marc Fisher
Journal:  Transl Stroke Res       Date:  2016-01-07       Impact factor: 6.829

10.  Safety, feasibility, and potential efficacy of intraarterial selective cooling infusion for stroke patients treated with mechanical thrombectomy.

Authors:  Chuanjie Wu; Wenbo Zhao; Hong An; Longfei Wu; Jian Chen; Mohammed Hussain; Yuchuan Ding; Chuanhui Li; Wenjing Wei; Jiangang Duan; Chunmei Wang; Qi Yang; Di Wu; Liqiang Liu; Xunming Ji
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-18       Impact factor: 6.200
View more
  7 in total

Review 1.  A clinically relevant model of focal embolic cerebral ischemia by thrombus and thrombolysis in rhesus monkeys.

Authors:  Di Wu; Jian Chen; Longfei Wu; Hangil Lee; Jingfei Shi; Mo Zhang; Yanhui Ma; Xiaoduo He; Zixin Zhu; Feng Yan; Chuanjie Wu; Yunxia Duan; Yongjuan Fu; Sijie Li; Xinglong Zhi; Xuxiang Zhang; Shengli Li; Yuchuan Ding; Xunming Ji
Journal:  Nat Protoc       Date:  2022-06-27       Impact factor: 17.021

Review 2.  Recanalization Therapy for Acute Ischemic Stroke with Large Vessel Occlusion: Where We Are and What Comes Next?

Authors:  Mohammad Shafie; Wengui Yu
Journal:  Transl Stroke Res       Date:  2021-01-06       Impact factor: 6.829

3.  AKAP12 Supports Blood-Brain Barrier Integrity against Ischemic Stroke.

Authors:  Ji Hae Seo; Takakuni Maki; Nobukazu Miyamoto; Yoon Kyong Choi; Kelly K Chung; Gen Hamanaka; Ji Hyun Park; Emiri T Mandeville; Hajime Takase; Kazuhide Hayakawa; Josephine Lok; Irwin H Gelman; Kyu-Won Kim; Eng H Lo; Ken Arai
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

4.  Ischemia-induced cleavage of OPA1 at S1 site aggravates mitochondrial fragmentation and reperfusion injury in neurons.

Authors:  Xiang Li; Haiying Li; Zhongmou Xu; Cheng Ma; Tianyi Wang; Wanchun You; Zhengquan Yu; Haitao Shen; Gang Chen
Journal:  Cell Death Dis       Date:  2022-04-08       Impact factor: 8.469

Review 5.  Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy.

Authors:  Yinghua Jiang; Ning Liu; Jinrui Han; Yadan Li; Pierce Spencer; Samuel J Vodovoz; Ming-Ming Ning; Gregory Bix; Prasad V G Katakam; Aaron S Dumont; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2020-11-02       Impact factor: 6.829

6.  Soluble Epoxide Hydrolase Blockade after Stroke Onset Protects Normal but Not Diabetic Mice.

Authors:  Catherine M Davis; Wenri H Zhang; Elyse M Allen; Thierno M Bah; Robert E Shangraw; Nabil J Alkayed
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

7.  Fast high-resolution metabolic imaging of acute stroke with 3D magnetic resonance spectroscopy.

Authors:  Yao Li; Tianyao Wang; Tianxiao Zhang; Zengping Lin; Yudu Li; Rong Guo; Yibo Zhao; Ziyu Meng; Jun Liu; Xin Yu; Zhi-Pei Liang; Parashkev Nachev
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.